5-Aminosalicylic acid for the treatment of inflammatory bowel disease
- 1 August 1984
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 87 (2) , 480-481
- https://doi.org/10.1016/0016-5085(84)90749-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- 5-AMINOSALICYLIC ACID AS RECTAL ENEMA IN ULCERATIVE COLITIS PATIENTS UNABLE TO TAKE SULPHASALAZINEThe Lancet, 1984
- TREATMENT OF ULCERATIVE COLITIS WITH ORAL 5-AMINOSALICYLIC ACID IN PATIENTS UNABLE TO TAKE SULPHASALAZINEThe Lancet, 1983
- Colonic release of 5‐amino salicylic acid from an oral preparation in active ulcerative colitis.British Journal of Clinical Pharmacology, 1983
- Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth.BMJ, 1983
- Studies of two novel sulfasalazine analogs, ipsalazide and balsalazideDigestive Diseases and Sciences, 1983
- Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.Gut, 1982
- 5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in HumansGastroenterology, 1982
- An oral preparation to release drugs in the human colon.British Journal of Clinical Pharmacology, 1982